TerminatedNot applicableNCT02830763
Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
Studying Primary triglyceride deposit cardiomyovasculopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Principal Investigator
- Kenichi Hirano, MD, Ph.DDepartment of Cardiovascular Medicine, Faculty of Internal Medicine, Graduate School of Osaka University, Japan
- Intervention
- CNT-02(dietary_supplement)
- Enrollment
- 2 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2016 – 2019
Study locations (7)
- IRCCS San Raffaele, Rome, Lazio, Italy
- San Filippo Neri Hospital, Rome, Lazio, Italy
- Catholic University, Milan, Lombardy, Italy
- Fondazione Ospedale San Camillo IRCCS, Lido, Venice, Italy
- Aomori Prefectural Chuo Hospital, Aomori, Aomori, Japan
- Tohoku University, Sendai, Miyagi, Japan
- Graduate School of Osaka University, Suita, Osaka, Japan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02830763 on ClinicalTrials.gov